STUART, Fla., March 08, 2022 (GLOBE NEWSWIRE) -- GelStat Corporation ("GelStat" or the "Company") (OTCPink:GSAC), a development stage company focused on the marketing of over-the-counter and other non-prescription, natural consumer health care products, today provided several updates related to its ongoing capital markets activities and corporate initiatives. As previously announced, the Company is in the process of conducting a Regulation A+, Tier 2, equity financing of up to $5 million (the “Public Offering”).
GelStat Provides Corporate Update on Capital Restructuring
Globe Newswire - Press Release
All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here
/amazon%20holiday%20delivery%20boxes%20by%20Cineberg%20via%20iStock.jpg)
/NVIDIA%20Corp%20logo%20on%20phone%20and%20AI%20chip-by%20Below%20the%20Sky%20via%20Shutterstock.jpg)
/Semiconductor%20Chip%20by%20Gorodenkoff%20via%20Shutterstock.jpg)
/Lululemon%20Athletica%20inc_%20leggings%20by-%20Sorbis%20via%20Shutterstock.jpg)
/Palo%20Alto%20Networks%20Inc%20HQ%20sign-by%20Tada%20Images%20via%20Shutterstock.jpg)